Genmab is seeking to out-license HuMax-IL8, a human antibody with potential in autoimmune disease and oncology.

A Non-Confidential Brochure is available.

A confidential data package is available after execution of a suitable non-disclosure agreement (CDA). Interested parties may request a one way CDA or a two way CDA.

Registered users may access the Confidential Data Room here.